Among the target genes of these miRNAs in the cell cycle pathway, TP53[34], CDKN2A[34], SKP2[35], [36], CCNE1[36], MCM4[36], CDK1 [37] and TGFB3[38] have been extensively studied as anticancer targets in endometrial cancer. This evidence concerns the gene CDK1 and endometrial cancer.